Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: Fertility recovery and first unassisted conception with term delivery at age over 40

BACKGROUND: The use of autologous platelet-rich plasma as an ovarian treatment has not been standardized and remains controversial. CASE PRESENTATION: A 41½-year old woman with diminished ovarian reserve (serum anti- Müllerian hormone = 0.163 mg/mL) and a history of 10 unsuccessful in vitro fertiliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Sills, E. Scott, Rickers, Natalie S., Wood, Samuel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Knowledge E 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778756/
https://www.ncbi.nlm.nih.gov/pubmed/33426419
http://dx.doi.org/10.18502/ijrm.v18i12.8030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778756/
https://www.ncbi.nlm.nih.gov/pubmed/33426419
http://dx.doi.org/10.18502/ijrm.v18i12.8030

Ejemplares similares